| LMRNX | VBINX | LMRNX / VBINX | |
| Total Expense Ratio | 0.69 | 0.18 | 383% |
| Annual Report Gross Expense Ratio | 0.69 | 0.18 | 383% |
| Fund Existence | 18 years | 34 years | - |
| Gain YTD | 2.082 | 4.938 | 42% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 907M | 64.1B | 1% |
| Annual Yield % from dividends | 0.95 | 1.89 | 51% |
| Returns for 1 year | 9.05 | 11.81 | 77% |
| Returns for 3 years | 41.79 | 31.28 | 134% |
| Returns for 5 years | 37.01 | 20.98 | 176% |
| Returns for 10 years | 119.23 | 99.59 | 120% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| CMVYX | 17.57 | 0.20 | +1.15% |
| Columbia Select Mid Cap Value Instl 3 | |||
| FACSX | 56.32 | 0.54 | +0.97% |
| Nuveen Mid Cap Value Opportunities C | |||
| VADGX | 31.71 | 0.16 | +0.51% |
| Vanguard Advice Select Dividend Gr Admrl | |||
| ALLIX | 114.33 | -0.05 | -0.04% |
| AB Large Cap Growth I | |||
| HLHIX | 28.83 | -0.14 | -0.48% |
| Virtus KAR Health Sciences Inst | |||